A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val

Leukemia Research

Volumn 25, Issue 7, 2001, Pages 627-634

  Jordan, John Hendrik ^a   Fritsche Polanz, Robert ^a   Sperr, Wolfgang R ^a   Mitterbauer, Gerlinde ^a   Födinger, Manuela ^a   Schernthaner, Gerit Holger ^a   Christian Bankl, Hans ^b   Gebhart, Walter ^c   Chott, Andreas ^b   Lechner, Klaus ^a   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Division of General Pediatrics and Neonatology   (Austria)

Author keywords

Classification; Disease criteria; Mastocytosis; Prognosis

Indexed keywords

TRYPTASE;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL INFILTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; MAST CELL; MULTIPLE ORGAN FAILURE; MUTATION; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SPLENOMEGALY; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

ADULT; AMINO ACID SUBSTITUTION; ANEMIA; BONE MARROW; CELL COUNT; CLONE CELLS; CODON; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DOSAGE COMPENSATION, GENETIC; FEMALE; HUMANS; HYPOTENSION; MAST CELLS; MASTOCYTOSIS; MUTATION, MISSENSE; MYELOID CELLS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ANDROGEN; SERINE ENDOPEPTIDASES; SHOCK; SYNCOPE; TRYPTASES; URTICARIA PIGMENTOSA;

EID: 0034991021     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00019-4     Document Type: Article

References (37)

1. Mast cells and mast cell neoplasia: A review
2. Tissue mast cells in health and disease
3. Classification and diagnosis of mastocytosis: Current status
4. Biology, classification and treatment of human mastocytosis
5. Systemic mast cell disease. Analysis of 58 cases and literature review
6. Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital
7. The natural course of urticaria pigmentosa
8. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis
9. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
10. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
11. Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
12. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting
13. Bone marrow findings in systemic mastocytosis
14. Mast cell leukemia: Report of a case and review of the literature
15. Mast cell leukaemia: Evidence for bone marrow origin of the pathologic clone
16. Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis
17. Significance of systemic mast cell disease with associated hematologic disorders
18. Blood findings in generalized mastocytosis: Evidence of frequent simultaneous occurrence of myeloproliferative disorders
19. Clinical and biologic diversity of leukemias occuring in patients with mastocytosis
20. Diagnostic value of immunostaining for tryptase in patients with mastocytosis
21. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
22. Two types of human mast cells that have distinct neutral protease compositions
23. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
24. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
25. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
26. Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
27. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation
28. Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliverative diseases, secondary neutrophilia, and reactive thrombocytosis
29. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
30. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
31. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemiam
32. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: An example of a smoldering case?
33. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Conference Report of the 'Year 2000 Working Conference on Mastocytosis'
34. Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis
35. Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings
36. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders